← FDA Drug Approvals (Drugs@FDA)
LORATADINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAXOSMITHKLINE · Approved 2003-02-10
Drug application
- FDA Application #
ANDA075822- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LORATADINE
- Generic name
- Loratadine
- Active ingredients
- LORATADINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- GLAXOSMITHKLINE
- First approval
- 2003-02-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown